Home > Boards > Free Zone > Penny Trading - Technical > MOMO'S BREAKOUT BOARD

$BIOAQ Throughout the process, BioAmber is successfully serving

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
motorcityAce Member Profile
 
Followed By 34
Posts 3,672
Boards Moderated 0
Alias Born 05/26/14
160x600 placeholder
Donald Trump, Joe Biden Clash Over Coronavirus in Final Presidential Debate--6th Update
President Trump and Democrat Joe Biden offered starkly differing views of the administration's handling of the coronavirus pandemic, traded accusations about their personal finances and questioned each other's records on economic and racial-justice issues in the final debate before the Nov. 3 election.
Top Company News of the Day
Donald Trump, Joe Biden Clash Over Coronavirus in Final Presidential Debate--5th Update
Donald Trump, Joe Biden Clash Over Coronavirus in Final Presidential Debate--4th Update
Donald Trump, Joe Biden Clash Over Coronavirus in Final Presidential Debate--2nd Update
Uber and Lyft Must Classify Drivers as Employees, Appeals Court Says
FTC Mulls Facebook Lawsuit as Staffers Support Antitrust Case
Goldman Promises Greater Scrutiny of Senior Executives Following 1MDB Settlement
Correction to Broadband Promises Unfulfilled Article -- Journal Report
NAB's 2nd Half Results to Include A$642 Million in New Provisions, Impairments
Goldman Sachs Malaysia Subsidiary Pleads Guilty in 1MDB Case -- 2nd Update
Walmart Files Pre-emptive Lawsuit Against Federal Government in Opioid Case -- Update
UK Consumer Confidence Plunges in October as Covid-19 Second Wave Takes Hold
Outside Spending for New York Political Races Tops $14 Million
Intel Hit as Consumers Flock to Lower-Cost Laptops, Datacenter Chips -- 2nd Update
Covid-19 Drug Remdesivir Fully Approved by FDA
Top Stories of the Day
Intel Hit as Consumers Flock to Lower-Cost Laptops, Datacenter Chips -- Update
Walmart Files Pre-emptive Lawsuit Against Federal Government in Opioid Case
U.S. Stocks Close Higher as Investors Eye Stimulus Talks
AT&T Pinched by Cord-Cutting and Closed Theaters --4th Update
AT&T Pinched by Cord-Cutting and Closed Theaters --3rd Update
Intel Hit as Consumers Flock to Lower-Cost Laptops, Datacenter Chips
FDA Approves Gilead Sciences' Remdesivir Treatment for Covid-19
AMC Bonds Fall Despite Theater Reopenings -- Update
Goldman Seizing or Withholding $174 Million From Executives for 1MDB Case -- 4th Update
The U.S. vs. China: The High Cost of the Technology Cold War -- Journal Report
motorcityAce   Monday, 12/02/19 02:41:35 PM
Re: None
Post # of 2143496 
$BIOAQ

Throughout the process, BioAmber is successfully serving our customer base and continues to supply high-quality bio-succinic acid to companies around the world.  We would like to thank our customers for their support and willingness to work with us through this process.  With this favorable court decision, we are pleased to be able to continue operations in Sarnia to meet the growing demand we’re seeing from the market,” stated Rick Eno, Chief Executive Officer.  “In the longer term, BioAmber has a number of strategic and financial investors evaluating an investment as part of the SISP.  We are optimistic that the closing of a transaction will provide our customers long-term supply assurance from the Sarnia facility. We will continue to provide updates throughout the process.”

Earning a current market cap value of $9.2M, BIOAQ has a significant war chest ($4.6M) of cash on the books, which compares with about $4.9M in total current liabilities. BIOAQ is pulling in trailing 12-month revenues of $14.9M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 754.6%. This is an exciting story, and we look forward to a follow-up chapter as events transpire. 



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences